SOD1 and amyotrophic lateral sclerosis: Here, we evaluated the in vivo efficacy of these compounds in Drosophila models of ALS, precisely those expressing pan-neuronal human SOD1<sup>A4V</sup> or SOD1<sup>G85R</sup> mutations.